Cobas 4800 HPV detection in the cervical, vaginal and urine samples of women with high-grade CIN before and after treatment

Journal of Clinical Pathology

Volumn 68, Issue 7, 2015, Pages 567-570

  Stanczuk, Grazyna A ^a   Currie, Heather ^a   Baxter, Gwen ^a   Foster, Adele ^a   Gibson, Lindsay ^a   Graham, Catriona ^b   Cuschieri, Kate ^c  

^a DUMFRIES AND GALLOWAY ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; COLPOSCOPY; COMPARATIVE STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; MAJOR CLINICAL STUDY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; URINALYSIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINA SMEAR; WART VIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; EVALUATION STUDY; GENETICS; HIGH THROUGHPUT SEQUENCING; LABORATORY DIAGNOSIS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; TREATMENT OUTCOME; UNITED KINGDOM; URINE; UTERINE CERVICAL NEOPLASMS; UTERINE CERVIX; VAGINA; VIROLOGY; YOUNG ADULT;

VIRUS DNA;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; DNA, VIRAL; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; REPRODUCIBILITY OF RESULTS; SCOTLAND; SPECIMEN HANDLING; TREATMENT OUTCOME; URINALYSIS; URINE; UTERINE CERVICAL NEOPLASMS; VAGINA; YOUNG ADULT;

EID: 84933182774     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2014-202851     Document Type: Article

References (11)

1. Arbyn M, Ronco G, Anttila A, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 2012;30(Suppl 5): F88-99. Erratum in: Vaccine 2013;31:6266.
2. Uijterwaal MH, Verhoef VM, Snijders PJ, et al. Arguments in favor of HPV testing for cervical screening and post-treatment CIN2+ monitoring. Expert Rev Mol Diagn 2014;14:245-8.
3. Saslow D, Solomon D, Lawson HW, et al., ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72.
4. Albrow R, Blomberg K, Kitchener H, et al. Interventions to improve cervical cancer screening uptake amongst young women: a systematic review. Acta Oncol 2014;53:445-51.
5. Snijders PJ, Verhoef VM, Arbyn M, et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013;132:2223-36.
6. Arbyn M, Verdoodt F, Snijders P, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol 2014;15:172-83.
7. Pathak N, Dodds J, Zamora J, et al. Accuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysis. BMJ 2014;349:g5264.
8. O'Leary MC, Sinka K, Robertson C, et al. HPV type-specific prevalence using a urine assay in unvaccinated male and female 11- to 18-year olds in Scotland. Br J Cancer 2011;104:1221-6.
9. Sonnenberg P, Clifton S, Beddows S, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Britain: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet 2013;382:1795-806.
10. Quest for improved, women friendly cervical screening continued: Evaluation of HPV DNA testing in primary cervical screening. An operational study in Dumfries and Galloway-(12/WS/0085).
11. Cubie HA, Canham M, Moore C, et al. Evaluation of commercial HPV assays in the context of post-treatment follow-up: Scottish Test of Cure Study (STOCS-H). J Clin Pathol 2014;67:458-63.